Jana Johnson, MD
Dermatology · Sioux Falls, SDNPI 1295701092
Payments from drug & device makers
Across 2,210 payments — averaging $944.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$436K
- Janssen Scientific Affairs, LLC$355K
- UCB, Inc.$301K
- Johnson & Johnson$279K
- Incyte Corporation$237K
- Regeneron Healthcare Solutions, Inc.$148K
- plus $332K from 11 others
What the payments were for
- Consulting fees$38,9932%
- Speaking & faculty fees$1,721,82582%
- Travel & lodging$303,49315%
- Food & beverage$22,4891%
- Education$5740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 470 | $436,272 |
| Janssen Scientific Affairs, LLC | 245 | $354,639 |
| UCB, Inc. | 329 | $301,450 |
| Johnson & Johnson | 255 | $278,632 |
| Incyte Corporation | 339 | $236,546 |
| Regeneron Healthcare Solutions, Inc. | 189 | $147,923 |
| Lilly USA, LLC | 154 | $101,397 |
| Sanofi | 64 | $82,144 |
| Dermavant Sciences, Inc. | 70 | $69,586 |
| Bristol Myers Squibb | 52 | $64,935 |
| Pfizer | 23 | $13,096 |
| Novartis | 4 | $526 |
| AbbVie | 12 | $168 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| DUSA Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,087,374 in reported general payments places this provider in the 95th percentile of 44 dermatology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $43,726 |
| Minocycline Hcl | 18 | $682 |
| Fluocinonide | 11 | $348 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sioux Falls
- Carmen SchwartzSioux Falls$10K
- Sarah SarbackerSioux Falls$8K
- Kendra WatsonSioux Falls$6K
- Valerie FlynnSioux Falls$3K
- Anna BahnsonSioux Falls$2K
- Kelly JerstadSioux Falls$2K
- Anna SonstegardSioux Falls$1K
- Lainee GoettscheSioux Falls$844
- Brian KnutsonSioux Falls$761
- William BrunnerSioux Falls$645
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.